These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 23158016)

  • 1. Clinical outcome in IL-10- and IL-10 receptor-deficient patients with or without hematopoietic stem cell transplantation.
    Engelhardt KR; Shah N; Faizura-Yeop I; Kocacik Uygun DF; Frede N; Muise AM; Shteyer E; Filiz S; Chee R; Elawad M; Hartmann B; Arkwright PD; Dvorak C; Klein C; Puck JM; Grimbacher B; Glocker EO
    J Allergy Clin Immunol; 2013 Mar; 131(3):825-30. PubMed ID: 23158016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of interleukin-10 signaling and infantile inflammatory bowel disease: implications for diagnosis and therapy.
    Kotlarz D; Beier R; Murugan D; Diestelhorst J; Jensen O; Boztug K; Pfeifer D; Kreipe H; Pfister ED; Baumann U; Puchalka J; Bohne J; Egritas O; Dalgic B; Kolho KL; Sauerbrey A; Buderus S; Güngör T; Enninger A; Koda YK; Guariso G; Weiss B; Corbacioglu S; Socha P; Uslu N; Metin A; Wahbeh GT; Husain K; Ramadan D; Al-Herz W; Grimbacher B; Sauer M; Sykora KW; Koletzko S; Klein C
    Gastroenterology; 2012 Aug; 143(2):347-55. PubMed ID: 22549091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unrelated donor hematopoietic stem cell transplantation for infantile enteropathy due to IL-10/IL-10 receptor defect.
    Gassas A; Courtney S; Armstrong C; Kapllani E; Muise AM; Schechter T
    Pediatr Transplant; 2015 Jun; 19(4):E101-3. PubMed ID: 25761563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic Characterization of Very Early-Onset Inflammatory Bowel Disease with Interleukin-10 Signaling Deficiency: Based on a Large Cohort Study.
    Zheng C; Huang Y; Hu W; Shi J; Ye Z; Qian X; Huang Z; Xue A; Wang Y; Lu J; Tang Z; Wu J; Wang L; Peng K; Zhou Y; Miao S; Sun H
    Inflamm Bowel Dis; 2019 Mar; 25(4):756-766. PubMed ID: 30212871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients with early relapse of primary hemophagocytic syndromes or with persistent CNS involvement may benefit from immediate hematopoietic stem cell transplantation.
    Sparber-Sauer M; Hönig M; Schulz AS; zur Stadt U; Schütz C; Debatin KM; Friedrich W
    Bone Marrow Transplant; 2009 Sep; 44(6):333-8. PubMed ID: 19252534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful hematopoietic stem cell transplantation from an unrelated donor in a child with interferon gamma receptor deficiency.
    Moilanen P; Korppi M; Hovi L; Chapgier A; Feinberg J; Kong XF; Boisson-Dupuis S; Arola M; Casanova JL; Saarinen-Pihkala UM
    Pediatr Infect Dis J; 2009 Jul; 28(7):658-60. PubMed ID: 19451859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [T-cell-depleted HLA non-identical bone marrow transplantation in the child: prevention of graft-versus-host reaction by administration of donor T lymphocytes alloreactive against the recipient].
    Cavazzana-Calvo M; André-Schmutz I; Hacein-Bey S; Schindler J; Vitetta H; Dupuis S; Quartier P; Chedeville G; Vilmer E; Casanova JL; Buffet R; Caillat-Zucman S; Radford I; Le Deist F; Fischer A
    J Soc Biol; 2001; 195(1):65-8. PubMed ID: 11530503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-10 and interleukin-10-receptor defects in inflammatory bowel disease.
    Shah N; Kammermeier J; Elawad M; Glocker EO
    Curr Allergy Asthma Rep; 2012 Oct; 12(5):373-9. PubMed ID: 22890722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-10 and IL-10 receptor defects in humans.
    Glocker EO; Kotlarz D; Klein C; Shah N; Grimbacher B
    Ann N Y Acad Sci; 2011 Dec; 1246():102-7. PubMed ID: 22236434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining combined immunodeficiency.
    Roifman CM; Somech R; Kavadas F; Pires L; Nahum A; Dalal I; Grunebaum E
    J Allergy Clin Immunol; 2012 Jul; 130(1):177-83. PubMed ID: 22664165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single-center study of hematopoietic stem cell transplantation for primary immune deficiencies (PIDD).
    Dinardo L; Brown V; Perez E; Bunin N; Sullivan KE
    Pediatr Transplant; 2012 Feb; 16(1):63-72. PubMed ID: 22093026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges in the use of allogeneic hematopoietic SCT for ectodermal dysplasia with immune deficiency.
    Fish JD; Duerst RE; Gelfand EW; Orange JS; Bunin N
    Bone Marrow Transplant; 2009 Feb; 43(3):217-21. PubMed ID: 18794870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment of idiopathic colitis related to XIAP deficiency with allo-HSCT using reduced-intensity conditioning.
    Tsuma Y; Imamura T; Ichise E; Sakamoto K; Ouchi K; Osone S; Ishida H; Wada T; Hosoi H
    Pediatr Transplant; 2015 Feb; 19(1):E25-8. PubMed ID: 25412586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and virological characteristics of 15 patients with chronic active Epstein-Barr virus infection treated with hematopoietic stem cell transplantation.
    Gotoh K; Ito Y; Shibata-Watanabe Y; Kawada J; Takahashi Y; Yagasaki H; Kojima S; Nishiyama Y; Kimura H
    Clin Infect Dis; 2008 May; 46(10):1525-34. PubMed ID: 18419486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful outcome with second hematopoietic stem cell transplantation in a patient with IL-10R deficiency.
    Kuşkonmaz B; Ayvaz D; Aydemir Y; Erman B; Tavil B; Özen H; Tezcan I; Çetinkaya DU
    Bone Marrow Transplant; 2016 Apr; 51(4):615-6. PubMed ID: 26691419
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of IL-18 and sIL2R on aGVHD occurrence after hematopoietic stem cell transplantation in some Iranian patients.
    Shaiegan M; Iravani M; Babaee GR; Ghavamzadeh A
    Transpl Immunol; 2006 Jan; 15(3):223-7. PubMed ID: 16431290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-10 in humans: lessons from the gut, IL-10/IL-10 receptor deficiencies, and IL-10 polymorphisms.
    Engelhardt KR; Grimbacher B
    Curr Top Microbiol Immunol; 2014; 380():1-18. PubMed ID: 25004811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic transplantation successfully corrects immune defects, but not susceptibility to colitis, in a patient with nuclear factor-kappaB essential modulator deficiency.
    Pai SY; Levy O; Jabara HH; Glickman JN; Stoler-Barak L; Sachs J; Nurko S; Orange JS; Geha RS
    J Allergy Clin Immunol; 2008 Dec; 122(6):1113-1118.e1. PubMed ID: 18851875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematopoietic stem cell transplantation for hemophagocytic lymphohistiocytosis: a retrospective analysis of data from the Italian Association of Pediatric Hematology Oncology (AIEOP).
    Cesaro S; Locatelli F; Lanino E; Porta F; Di Maio L; Messina C; Prete A; Ripaldi M; Maximova N; Giorgiani G; Rondelli R; Aricò M; Fagioli F
    Haematologica; 2008 Nov; 93(11):1694-701. PubMed ID: 18768529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic stem cell transplantation using myeloablative and reduced-intensity conditioning in patients with major histocompatibility complex class II deficiency.
    Al-Mousa H; Al-Shammari Z; Al-Ghonaium A; Al-Dhekri H; Al-Muhsen S; Al-Saud B; Arnaout R; Al-Seraihy A; Al-Jefri A; Al-Ahmari A; Ayas M; El-Solh H
    Biol Blood Marrow Transplant; 2010 Jun; 16(6):818-23. PubMed ID: 20079864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.